Literature DB >> 23246229

Effects of berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort.

Xiao-Wen Jiang1, Yi Zhang, Ya-Li Zhu, Hao Zhang, Kun Lu, Fen-Fang Li, Hai-Yan Peng.   

Abstract

OBJECTIVE: Recurrent aphthous stomatitis (RAS) is a common oral mucosal disease, yet effective therapeutic approaches are lacking. This study aimed to determine the effects of application of berberine gelatin in the treatment of minor RAS (MiRAS).
METHODS: A randomized, double-blind, placebo-controlled, clinical trial was performed. The gelatin containing berberine (5 mg/g) or vehicle only was applied 4 times per day for 5 days. Clinical evaluation included pain level, size, erythema, and exudation of certain ulcers on days 1, 2, 4, and 6.
RESULTS: A total of 84 subjects fulfilled the study without obvious side effects. Berberine gelatin treatment reduced the ulcer pain score compared with placebo gelatin (P < 0.05). Ulcer size was significantly reduced (P < 0.05) and lower erythema (P < 0.05) and exudation (P < 0.05) levels were associated with berberine treatment.
CONCLUSIONS: Berberine gelatin may be a safe and effective treatment for MiRAS.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246229     DOI: 10.1016/j.oooo.2012.09.009

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  12 in total

Review 1.  Effects of natural extracts in the treatment of oral ulcers: A systematic review of evidence from experimental studies in animals.

Authors:  Schilin D Wen; Eulàlia Sans-Serramitjana; Javiera F Santander; Mariela R Sánchez; Paulina Salazar-Aguilar; Andrea B Zepeda; Susana I Alvarado; Ignacia B Miranda
Journal:  J Clin Exp Dent       Date:  2021-10-01

Review 2.  Drug Candidates for Autoimmune Diseases.

Authors:  Sabrina Saurin; Myriam Meineck; Gerhard Erkel; Till Opatz; Julia Weinmann-Menke; Andrea Pautz
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-20

3.  Berberine exerts an anti-inflammatory role in ocular Behcet's disease.

Authors:  Yan Yang; Qin Wang; Manyun Xie; Ping Liu; Xin Qi; Xiao Liu; Zhuo Li
Journal:  Mol Med Rep       Date:  2016-12-05       Impact factor: 2.952

Review 4.  Metformin and berberine, two versatile drugs in treatment of common metabolic diseases.

Authors:  Haoran Wang; Chen Zhu; Ying Ying; Lingyu Luo; Deqiang Huang; Zhijun Luo
Journal:  Oncotarget       Date:  2017-09-11

5.  Berberine Alleviates Paclitaxel-Induced Neuropathy.

Authors:  Ramin Rezaee; Alireza Monemi; Mohammad Amin SadeghiBonjar; Mahmoud Hashemzaei
Journal:  J Pharmacopuncture       Date:  2019-06-30

Review 6.  Evidence-based effectiveness of herbal treatment modality for recurrent aphthous ulcers - A systematic review and meta-analysis.

Authors:  Adit Srivastava; ShivaKumar Gc; Swarnasmita Pathak; Ekta Ingle; Anjali Kumari; Sahana Shivakumar; Navin Kumar Pg; Akhilesh Kumar Singh
Journal:  Natl J Maxillofac Surg       Date:  2021 Sep-Dec

Review 7.  Efficacy and safety of topical herbal medicine treatment on recurrent aphthous stomatitis: a systemic review.

Authors:  Chun-Lei Li; He-Long Huang; Wan-Chun Wang; Hong Hua
Journal:  Drug Des Devel Ther       Date:  2015-12-31       Impact factor: 4.162

8.  Short-Term Efficacy of Pudilan Keyanning Toothpaste in Treatment of Minor Recurrent Aphthous Ulcers.

Authors:  Yingming Yang; Tao Zhang; Zibo Dong; Yang Wu; Xiao Hong; Tao Hu
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-14       Impact factor: 2.629

9.  Berberine and its structural analogs have differing effects on functional profiles of individual gut microbiomes.

Authors:  Leyuan Li; Lu Chang; Xu Zhang; Zhibin Ning; Janice Mayne; Yang Ye; Alain Stintzi; Jia Liu; Daniel Figeys
Journal:  Gut Microbes       Date:  2020-05-06

Review 10.  Foods with Potential Prooxidant and Antioxidant Effects Involved in Parkinson's Disease.

Authors:  Alejandra Guillermina Miranda-Díaz; Andrés García-Sánchez; Ernesto Germán Cardona-Muñoz
Journal:  Oxid Med Cell Longev       Date:  2020-08-03       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.